Drug Profile
Isoflurane intravenous - Yichang Humanwell Pharmaceutical
Alternative Names: emulsified isoflurane - Yichang Humanwell PharmaceuticalLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Yichang Humanwell Pharmaceutical
- Developer West China Hospital Sichuan University; Yichang Humanwell Pharmaceutical
- Class General anaesthetics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaesthesia
Most Recent Events
- 30 Sep 2020 No development reported - Phase-II for Anaesthesia in China (Inhalation) (ChiCTR-IIR17012142)
- 30 Sep 2020 No development reported - Phase-II for Anaesthesia in China (IV) (ChiCTR-IIR17012142)
- 27 Jul 2017 Phase-II clinical trials in Anaesthesia in China (Inhalation) before July 2017 (ChiCTR-IIR17012142)